Cargando…
Barriers to human papillomavirus (HPV) vaccination among young adults, aged 18–35
In the United States (US), an estimated 35,900 human papillomavirus (HPV)-related cancers are diagnosed annually. HPV vaccines are projected to eliminate ∼90% of these cancers. Routine vaccination is recommended at age 11–12 with “catch-up” vaccination through age 26 and shared clinical decision mak...
Autores principales: | Muthukrishnan, Meera, Loux, Travis, Shacham, Enbal, Tiro, Jasmin A., Arnold, Lauren D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502683/ https://www.ncbi.nlm.nih.gov/pubmed/36161130 http://dx.doi.org/10.1016/j.pmedr.2022.101942 |
Ejemplares similares
-
Patients' self-reported barriers to colon cancer screening in federally qualified health center settings
por: Muthukrishnan, Meera, et al.
Publicado: (2019) -
The Longitudinal Impact of Maternal Depression and Neighborhood Social Context on Adolescent Mental Health
por: Lew, Daphne, et al.
Publicado: (2022) -
Differences in human papillomavirus (HPV) vaccine uptake by nativity status among men aged 18–34 years
por: Adjei Boakye, Eric, et al.
Publicado: (2019) -
Provider perspectives on communication and dismissal policies with HPV vaccine hesitant parents
por: Francis, Jenny K.R., et al.
Publicado: (2021) -
Factors associated with the human papillomavirus (HPV) vaccination across three countries following vaccination introduction
por: Nickel, Brooke, et al.
Publicado: (2017)